Guided Therapeutics (GTHP) EBIT Margin (2010 - 2025)
Guided Therapeutics (GTHP) reported EBIT Margin of -120.34% for Q4 2025, up 53279.66 percentage points from -53400.00% a year earlier and up 687.99 percentage points from the prior quarter.
Powered by 
Analysis
Guided Therapeutics (GTHP) EBIT Margin (2010 - 2025) Analysis & Trends
For FY2025, Guided Therapeutics posted EBIT Margin of -309.26%, up 29805.03 percentage points from FY2024.
- EBIT Margin has a five-year change of +722.12 percentage points (FY2020 to FY2025).
- By year, EBIT Margin came in at -30114.29% in FY2024 (-26586.73 pp), -3527.55% in FY2023 (+22110.91 pp), -25638.46% in FY2022 (-22722.41 pp) and -2916.05% in FY2021 (-1884.68 pp).
- The Q4 2025 figure ranks as the highest quarterly EBIT Margin since Q4 2012.
- The high point for year-over-year EBIT Margin in five years was Q4 2025 (a gain of 53279.66 percentage points); the low point was Q4 2024 (a drop of 51884.38 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn | 17.40% |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn | 13.44% |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn | 17.99% |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn | 33.60% |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn | 18.08% |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn | 25.18% |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn | 21.65% |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn | 29.48% |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn | 13.31% |
| 10 | Guided Therapeutics | 19.31 Mn | 18.78 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -120.34% |
| Sep 30, 2025 | -808.33% |
| Jun 30, 2025 | -652.14% |
| Dec 31, 2024 | -53,400.00% |
| Mar 31, 2024 | -5,983.33% |
| Dec 31, 2023 | -1,515.63% |
| Jun 30, 2023 | -3,420.45% |
| Mar 31, 2023 | -3,831.82% |
| Sep 30, 2022 | -40,800.00% |
| Jun 30, 2022 | -14,340.00% |
| Mar 31, 2022 | -8,860.00% |
| Dec 31, 2021 | -725.00% |
| Sep 30, 2021 | -2,563.16% |
| Jun 30, 2021 | -28,050.00% |
| Dec 31, 2020 | -1,152.00% |
| Sep 30, 2020 | -198.70% |
| Dec 31, 2019 | -1,031.25% |
| Sep 30, 2019 | -18,800.00% |
| Jun 30, 2019 | -32,700.00% |
| Mar 31, 2019 | -1,427.78% |
API Access
Guided Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=GTHP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "GTHP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=GTHP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();